Sale!

t1221 p13q22 ETV6-RUNX1 TEL-AML1 PCR Qualitative Test

1,000 د.إ

-23%

The “t(12;21)(p13;q22) ETV6-RUNX1 (TEL-AML1) PCR Qualitative Test” is a specialized diagnostic tool used for the detection of the ETV6-RUNX1 gene fusion, which results from a translocation between chromosomes 12 and 21. This genetic anomaly is particularly significant in the context of pediatric acute lymphoblastic leukemia (ALL), where it serves as a common chromosomal alteration. The test employs Polymerase Chain Reaction (PCR) technology to qualitatively identify the presence of this specific gene fusion, offering crucial information for the diagnosis, prognosis, and treatment planning of affected individuals.

Administered by DNA Labs UAE, a leading facility in genetic testing, this test is priced at 1000 AED. DNA Labs UAE is renowned for its state-of-the-art technology and expertise in genetic diagnostics, providing accurate and reliable results. The test’s qualitative nature means it aims to detect the presence or absence of the ETV6-RUNX1 fusion gene, rather than quantifying its amount or concentration in the sample. This information is vital for clinicians in making informed decisions regarding the management and therapeutic approach for patients with ALL, particularly in tailoring treatments to individual genetic profiles, thus enhancing the effectiveness of targeted therapies.

Home  Sample collection service available

  • 100% accuaret DNA Results
  • Ranked as Most trusted Genetic DNA Lab
Guaranteed Safe Checkout

t1221 p13q22 ETV6-RUNX1 TEL-AML1 PCR QUALITATIVE Test

Test Name: t1221 p13q22 ETV6-RUNX1 TEL-AML1 PCR QUALITATIVE Test

Components: Price: 1000.0 AED

Sample Condition: 3mL(2mLmin.) wholeblood/Bone marrowin1LavenderTop(EDTA) tube. Ship refrigerated. DO NOT FREEZE. Clinical history is mandatory.

Report Delivery: Sample by Mon/Thu by 11am; Report on Wed/Sat

Method: Real Time PCR

Test type: Leukemia

Doctor: Oncologist

Test Department: MOLECULAR DIAGNOSTICS

Pre Test Information: Clinical history is mandatory.

Test Details

The t(12;21) (p13;q22) ETV6-RUNX1 (TEL-AML1) PCR qualitative test is a diagnostic test used to detect the presence of a specific genetic abnormality known as the ETV6-RUNX1 fusion gene. This fusion gene is commonly found in pediatric patients with acute lymphoblastic leukemia (ALL).

The test involves extracting genetic material (DNA) from the patient’s blood or bone marrow sample. The DNA is then amplified using a technique called polymerase chain reaction (PCR), which specifically targets the ETV6-RUNX1 fusion gene.

If the fusion gene is present in the patient’s sample, the PCR amplification will produce a positive result, indicating the presence of the genetic abnormality.

This test is qualitative, meaning it determines the presence or absence of the ETV6-RUNX1 fusion gene, but does not provide information about the quantity or level of the fusion gene.

It is commonly used as part of the diagnostic workup for pediatric ALL patients to confirm the presence of the ETV6-RUNX1 fusion gene, which can help guide treatment decisions.

Test Name t1221 p13q22 ETV6-RUNX1 TEL-AML1 PCR QUALITATIVE Test
Components
Price 1000.0 AED
Sample Condition 3mL(2mLmin.) wholeblood\/Bone marrowin1LavenderTop(EDTA) tube.Shiprefrigerated.DONOT FREEZE. Clinical history is mandatory.
Report Delivery SamplebyMon / Thuby 11am;Report Wed / Sat
Method Real Time PCR
Test type Leukemia
Doctor Oncologist
Test Department: MOLECULAR DIAGNOSTICS
Pre Test Information Clinical history is mandatory.
Test Details

The t(12;21) (p13;q22) ETV6-RUNX1 (TEL-AML1) PCR qualitative test is a diagnostic test used to detect the presence of a specific genetic abnormality known as the ETV6-RUNX1 fusion gene. This fusion gene is commonly found in pediatric patients with acute lymphoblastic leukemia (ALL).

The test involves extracting genetic material (DNA) from the patient’s blood or bone marrow sample. The DNA is then amplified using a technique called polymerase chain reaction (PCR), which specifically targets the ETV6-RUNX1 fusion gene. If the fusion gene is present in the patient’s sample, the PCR amplification will produce a positive result, indicating the presence of the genetic abnormality.

This test is qualitative, meaning it determines the presence or absence of the ETV6-RUNX1 fusion gene, but does not provide information about the quantity or level of the fusion gene. It is commonly used as part of the diagnostic workup for pediatric ALL patients to confirm the presence of the ETV6-RUNX1 fusion gene, which can help guide treatment decisions.